Navigation Links
Dr. Ricky Takai, Expert in Designing and Managing Federal Evaluation Studies in Education, Joins Abt Associates
Date:2/3/2009

CAMBRIDGE, Mass., Feb. 3 /PRNewswire/ -- Abt Associates announced that Ricky Takai, Ph.D., has joined the company as Principal Associate. After a brief orientation to the firm, Dr. Takai will become the leader of the company's education work in September 2009. Dr. Takai brings his more than 20 years experience in the design and management of federal evaluation studies in the field of education to the company.

Most recently, Dr. Takai served as Associate Commissioner in the National Center for Education Evaluation and Regional Assistance, Institute of Education Sciences, U.S. Department of Education. In this role he was responsible for national evaluations of major federal education programs including Title I and IDEA. Prior to that, Dr. Takai served as the division director for program evaluation in the Planning and Evaluation Service. He has directed program evaluations in a wide range of education areas such as early reading, educational technology, professional development, math and science education, drug prevention, dropout prevention, high school reform, vocational and adult education, and postsecondary education. In addition, Dr. Takai has served as the Acting Assistant Secretary in the Office of Educational Research and Improvement and the Office of Vocational and Adult Education.

"Ricky's high level work in the field of education research and evaluation, as well as his knowledge of federal education initiatives over the last 20 years, make him a tremendous asset to our company broadly and our growing Education portfolio more specifically," said Kathleen Flanagan, Group Vice President for Domestic Policy at the company.

In 1996 and 2006, Dr. Takai received Presidential Rank Awards. Presidential Rank Awards are reserved for senior career federal employees who have a sustained record of professional, technical, and/or scientific achievement that is recognized throughout the agency and is acknowledged on a national or international level.

Dr. Takai holds a Ph.D. in sociology from Johns Hopkins University and a B.A. from Washington College.

Abt Associates applies scientific research, technical assistance and consulting expertise to a wide range of social, economic and health policy issues; international development; clinical trials and registries; and complex business problems. Founded in 1965, the company provides services to U.S. federal, state and local governments; international organizations and national governments; universities and foundations; media; and major corporations. Its staff of over 1,000 is located in Cambridge, Massachusetts; Atlanta, Georgia; Bethesda, Maryland; Durham, North Carolina; Lexington, Massachusetts (Abt Bio-Pharma Solutions, Inc.); New York, New York (Abt SRBI); and in Africa, Asia, Central Asia, Europe, Latin America, and the Middle East.


'/>"/>
SOURCE Abt Associates
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Global Experts Explore Entire Spectrum of Aids Vaccine Development
2. Celebrity Designer Ty Pennington to Host ADHD Experts on Call Program
3. Valeritas Hires Trade and Distribution Industry Expert for the Launch of the h-Patch(TM) Disposable Insulin Delivery Device
4. European Expert Consortium Combines Forces to Develop a Novel Pandemic Influenza Vaccine
5. Vicus Therapeutics Chief Executive Officer to Participate in BIOTECH 2007 Expert Panels
6. Valeritas Hires Senior Account Management Industry Expert for the Launch of the h-Patch(TM) Disposable Insulin Delivery Device
7. WHO Introduces the Helminth Drug Initiative With Special Supplement in the Expert Opinion on Drug Discovery
8. Expert Cardiologist Joins Quintiles Medical Group
9. California IVF Experts Tap Ethics Committee for Guidance
10. VIA Pharmaceuticals Expands Clinical Advisory Board With Leading Experts in Cardiovascular Disease
11. International Diabetes Experts Call for Stepped-Up Action and Shared Responsibility to Curb Rising Global Diabetes Epidemic and Impact
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... Feb. 17, 2017  If only one in ... a mutation-conferring resistance to chemotherapy, thousands of cancer ... has focused on finding these mutations in ever-smaller ... circulating tumor DNA in blood — to guide ... Unfortunately, however, detecting these genetic anomalies ...
(Date:2/16/2017)...  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company harnessing ... treatment for triple negative breast cancer (TNBC), announced today their ... program. The YEi Start in ... entrepreneurs grow their business in France ... selected to complete an intensive one week immersion in ...
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
Breaking Biology Technology:
(Date:2/3/2017)... A new independent identity strategy consultancy firm announces its ... to fill a critical niche in technical and policy ... Mark Crego and Janice Kephart together ... that span federal governments, the 9/11 Commission, private industry, ... has a common theme born from a shared passion ...
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
(Date:1/24/2017)... , Jan. 24, 2017 Biopharm ... of the laboratory use of nuclear magnetic resonance ... experienced end-users and profiled current practices, developments, trends ... as well as growth and opportunities. These areas ... suppliers, NMR instruments, needs and innovation requirements, hyphenated ...
Breaking Biology News(10 mins):